Aarvik Therapeutics: Funding, Investors & Team (Sep 2026)
Aarvik Therapeutics combines a unique, proprietary modular platform with multiple target mechanisms to develop novel molecules with an improved therapeutic index for oncology targets. Backed by the extensive scientific research, development, and investment expertise of its founders and Board members, Aarvik Therapeutics is applying its vision and passion to create transformational benefits for cancer patients.
Aarvik Therapeutics has raised $1.2M across 2 funding rounds on record, the most recent a Seed announced in Oct 2025.
Aarvik Therapeutics Company Profile and Key Stats
Latest funding round on record: Oct 2025.
Aarvik Therapeutics Funding Rounds
1 of 2 rounds was announced without a disclosed amount and is excluded from the total.
Aarvik Therapeutics raised $1.2M in a Seed announced in Dec 2024.
10 months later, a Seed was announced in Oct 2025 with no disclosed amount.
Aarvik Therapeutics Founders and Leadership Team
Contact details for the Aarvik Therapeutics team: 2 of 2 have an email address on file, 1 has a LinkedIn profile.
Start 14-day free trial →Aarvik Therapeutics Funding Compared to Other Biotechnology Startups
Funded Startups Like Aarvik Therapeutics in Biotechnology and Fremont
Companies Similar to Aarvik Therapeutics
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…
Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.
Cataract surgery is the single most common procedure performed in the United States annually. Despite…
InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…
Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…
Aarvik Therapeutics Funding FAQs
What does Aarvik Therapeutics do?
Aarvik Therapeutics combines a unique, proprietary modular platform with multiple target mechanisms to develop novel molecules with an improved therapeutic index for oncology targets. Backed by the extensive scientific research, development, and investment expertise of its founders and Board members, Aarvik Therapeutics is applying its vision and passion to create transformational benefits for cancer patients.
How much funding has Aarvik Therapeutics raised?
Aarvik Therapeutics has raised $1.2M across 2 rounds on record.
When did Aarvik Therapeutics last raise funding?
Aarvik Therapeutics' most recent funding round on record was announced in Oct 2025. The amount was not disclosed.
Who founded Aarvik Therapeutics?
FundedIQ lists Jagath Reddy Junutula (Founder) at Aarvik Therapeutics.
Who is the CEO of Aarvik Therapeutics?
Jagath Reddy Junutula, PhD is listed as CEO at Aarvik Therapeutics.
Where is Aarvik Therapeutics headquartered?
Aarvik Therapeutics is based in Fremont, California, United States.
How many employees does Aarvik Therapeutics have?
Aarvik Therapeutics is in the 11-50 employee band.
About FundedIQ's Aarvik Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Aarvik Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.